This looks like another stupid move.
The research business is cashflow breakeven.
The point of selling it is not clear to me.
I would have thought the research business is the platform for future discoveries/products.
I guess the bankers on the Board thought they needed to do something.
- Forums
- ASX - By Stock
- MAP
- Ann: Strategic transfer of Microba Research Services Unit to CMC
MAP
microba life sciences limited
Add to My Watchlist
0.00%
!
9.3¢

Ann: Strategic transfer of Microba Research Services Unit to CMC, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M |
Open | High | Low | Value | Volume |
9.3¢ | 9.4¢ | 9.2¢ | $8.201K | 88.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 126478 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 49153 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 126478 | 0.090 |
4 | 90644 | 0.089 |
3 | 262552 | 0.088 |
1 | 30000 | 0.085 |
2 | 204868 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 49153 | 1 |
0.094 | 8500 | 2 |
0.095 | 108639 | 2 |
0.096 | 28000 | 1 |
0.099 | 107500 | 1 |
Last trade - 14.01pm 07/08/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |